Show simple item record

dc.creatorGomer, Richard
Pilling, Darrell
dc.date.accessioned 2015-05-04T19:06:00Z
dc.date.available 2015-05-04T19:06:00Z
dc.date.issued 2012-05-29
dc.identifier.urihttps://hdl.handle.net/1911/80093
dc.description.abstract The present invention relates to the ability of SAP to suppress fibrocytes. It also relates to the ability of IL-12, laminin-1, cross-linked IgG and IgG aggregates to suppress fibrocytes. Methods and compositions for suppressing fibrocytes using these proteins are provided. These methods are useful in a variety of applications including treatment and prevention of fibrosing diseases such as scleroderma, pulmonary fibrosis and asthma. Finally, the invention includes assays for detecting the ability of various agents to modulate differentiation into fibrocytes. Such assays may also be used to diagnose scleroderma, pulmonary fibrosis, or other fibrosing diseases.
dc.format.extent 37 pp
dc.language.iso eng
dc.title Treatment of Fibrosis related disorders
dc.type Utility patent
dc.digitization.specificationsThis patent information was downloaded from the US Patent and Trademark website (http://www.uspto.gov/) as image-PDFs. The PDFs were OCRed for access purposes.
dc.contributor.publisher United States Patent and Trademark Office
dc.type.genre patents
dc.type.dcmi Text
dc.date.filed 2011-09-23
dc.identifier.patentID US8187608B2
dc.contributor.assignee Rice University
dc.identifier.citation Gomer, Richard and Pilling, Darrell, "Treatment of Fibrosis related disorders." Patent US8187608B2. issued 2012-05-29. Retrieved from https://hdl.handle.net/1911/80093.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record